Jens Panse

Also affiliated with Integrated Oncology (United States), Heinrich Heine University Düsseldorf, RWTH Aachen University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial”.

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Nature Medicine(2021)10.1038/s41591-021-01539-8

N/A

4.0DataRank · unranked

147 citations

Andreas Reiter, Deepti Radia, Michael W. Deininger, Tracy I. George, Jens Panse +19 more

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide

Nature Communications(2020)10.1038/s41467-020-14619-z

N/A

0DataRank · unranked

78 citations

Tim Luetkens, Sandra D. Scherer, Patricia M. Davis, Erica R. Vander Mause, Michael Olson +9 more

Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.036

N/A

0DataRank · unranked

27 citations

Tracy I. George, Philip M. Kluin, Andreas Reiter, Juliana Schwaab, Jens Panse +23 more

CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL

Hematological Oncology(2023)10.1002/hon.3163_15

N/A

0DataRank · unranked

6 citations

Andrés J.M. Ferreri, Mascha Binder, Peter Borchmann, Justin Hasenkamp, Stephan Stilgenbauer +45 more